Deerfield Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-870,000
| Closed | -$9.98M | – | 233 |
|
|
2023
Q3 | $9.98M | Hold |
870,000
| – | – | 0.22% | 57 |
|
|
2023
Q2 | $22M | Buy |
+870,000
| New | +$22M | 0.47% | 45 |
|
|
2020
Q1 | – | Sell |
-900,000
| Closed | -$14.6M | – | 100 |
|
|
2019
Q4 | $14.6M | Buy |
+900,000
| New | +$14.6M | 0.47% | 56 |
|
|
2018
Q1 | – | Sell |
-1,000,000
| Closed | -$35.8M | – | 122 |
|
|
2017
Q4 | $35.8M | Buy |
+1,000,000
| New | +$35.8M | 1.41% | 25 |
|
|
2014
Q3 | – | Sell |
-256,500
| Closed | -$8.72M | – | 137 |
|
|
2014
Q2 | $8.72M | Buy |
256,500
+139,811
| +120% | +$4.75M | 0.35% | 62 |
|
|
2014
Q1 | $3.68M | Buy |
+116,689
| New | +$3.68M | 0.15% | 90 |
|